Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia (Q37355664)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 August 2009
edit
Language Label Description Also known as
English
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia
scientific article published on 03 August 2009

    Statements

    Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia (English)
    Bing Z Carter
    Gary J Schiller
    Jessica K Altman
    Judith E Karp
    Jeannine Kassis
    Joseph Brandwein
    Wei Xu
    Duncan H Mak
    Eric LaCasse
    Christine Jacob
    Stephen J Morris
    Jacques Jolivet
    3 August 2009
    4741-4746

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit